Cambridge wings in with treble in UK angel awards
Cambridge technology companies earned three major accolades for their investors at the virtual UKBAA Angel Investment Awards; two of the businesses concerned are considered pioneers in DeepTech.
Cambridge Angels was a finalist in another category – the Angel Group of the Year – a title won by Par Equity.
A panel of 37 judges reviewed hundreds of nominations to select the leaders and trailblazers from the UK’s investment ecosystem.
Nyobolt – backed by IQ Capital and Cambridge Enterprise and creator of the world's fastest charging battery – was named winner in the Best Investment in Sustainable Innovation final sponsored by Innovate UK.
Nyobolt’s team of globally renowned experts have pioneered a new class of battery technology that achieves record-breaking, ultrafast charging and the world’s highest power batteries. This solves a critical need that other battery innovations, such as solid state, cannot meet.
It was Cambridge at the double in the DeepTech Investment of the Year final, sponsored by Playfair Capital.
DeepTech Investment of the Year was Cambridge GaN Devices – backed by Cambridge Angels, CCG, Martlet, individual angel investors, Parkwalk Advisors, IQ Capital, BGF, Foresight Williams and Cambridge Enterprise.
Headed by Giorgia Longobardi, founder and CEO, CGD was created to explore and develop a number of unique opportunities in power electronics made possible by the team’s proprietary application of Gallium Nitride to the silicon-based semiconductor transistor manufacturing process.
With silicon transistors widely acknowledged as having attained maximum efficiency, CGD’s power design engineers have developed a range of Gallium Nitride transistors that are over 100 times faster, lose 5–10 times less power and are four times smaller than existing silicon equivalents. The possibilities and range of potential applications for these transistors is almost endless in this increasingly digitally connected world.
The subsidiary DeepTech Investment of the Year – Rising Star Award was also captured by Cambridge Innovators.
The winner was PharmEnable, backed by individual angel investors, Access EIS, Cambridge Angels, Martlet Capital, o2h Ventures, The University of Cambridge Enterprise Fund and Wren Capital.
PharmEnable is designing the next generation of small molecule drugs. Its powerful AI platform explores novel areas of the chemical universe to find specific drugs for otherwise untreatable conditions.
The Awards celebrate the high growth and success in the angel and early-stage investment market – recognising the fastest growing brands and acknowledging the founders, angels, crowd funders and early-stage venture capital investors behind them.
The online ceremony celebrated the success and determination of the angel and early-stage investment community following a year of struggle and uncertainty because of the Covid pandemic.